Europe Authorizes Moderna's Combo Flu-COVID Vaccine Ahead of US Approval

Europe has become the first region to authorize Moderna's combination mRNA vaccine for flu and COVID-19, while the US FDA application was withdrawn last year under RFK Jr.'s anti-vaccine agenda. This regulatory divergence highlights the ongoing tension between federal health restrictions and international medical advancements. The situation underscores the impact of current administration policies on the speed of vaccine deployment.